This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ulthera, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations by Nicholas A Campbell in Ultrasound Treatment
Introduction
Nicholas A Campbell is an accomplished inventor based in Halifax, Canada. He has made significant contributions to the field of ultrasound treatment technology. His innovative work focuses on enhancing the efficacy of ultrasound applications, which has the potential to improve various medical treatments.
Latest Patents
Nicholas A Campbell holds a patent for "Systems and methods for enhancing efficacy of ultrasound treatment." This patent describes embodiments that enhance ultrasound efficacy through high efficiency, signal measurement, calibration, and assurance systems. The control system radio-frequency (RF) driver is designed to drive one or more focused ultrasound transducers. The RF driver includes power amplifiers with III-V semiconductors, such as gallium nitride (GaN) and gallium arsenide (GaAs), to efficiently provide high power with distinct narrow-band RF signals over a wide frequency range. Additionally, the RF driver features a power measurement and calibration system to monitor the amplitude and phase of the RF signal output from the power amplifier, estimating the amount of RF power delivered to the ultrasound transducers.
Career Highlights
Nicholas A Campbell is currently associated with Ulthera, Inc., where he continues to develop innovative solutions in ultrasound technology. His work has garnered attention for its potential impact on medical treatments and patient care.
Collaborations
Some of his notable coworkers include Charles D Emery and Wohsing P Chen, who contribute to the collaborative environment at Ulthera, Inc. Their combined expertise enhances the development of advanced ultrasound technologies.
Conclusion
Nicholas A Campbell's contributions to ultrasound treatment technology exemplify the importance of innovation in the medical field. His patent and ongoing work at Ulthera, Inc. highlight his commitment to improving healthcare through advanced technology.